These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 32614882)
1. A Systematic comparison of in vitro cell uptake and in vivo biodistribution for three classes of gold nanoparticles with saturated PEG coatings. Zhang Y; Liu AT; Cornejo YR; Van Haute D; Berlin JM PLoS One; 2020; 15(7):e0234916. PubMed ID: 32614882 [TBL] [Abstract][Full Text] [Related]
2. Coating Metal Nanoparticle Surfaces with Small Organic Molecules Can Reduce Nonspecific Cell Uptake. Van Haute D; Liu AT; Berlin JM ACS Nano; 2018 Jan; 12(1):117-127. PubMed ID: 29261281 [TBL] [Abstract][Full Text] [Related]
3. Size-dependent in vivo toxicity of PEG-coated gold nanoparticles. Zhang XD; Wu D; Shen X; Liu PX; Yang N; Zhao B; Zhang H; Sun YM; Zhang LA; Fan FY Int J Nanomedicine; 2011; 6():2071-81. PubMed ID: 21976982 [TBL] [Abstract][Full Text] [Related]
4. Detection of Phosphatidylcholine-Coated Gold Nanoparticles in Orthotopic Pancreatic Adenocarcinoma using Hyperspectral Imaging. England CG; Huang JS; James KT; Zhang G; Gobin AM; Frieboes HB PLoS One; 2015; 10(6):e0129172. PubMed ID: 26046360 [TBL] [Abstract][Full Text] [Related]
5. Mixed-charge nanoparticles for long circulation, low reticuloendothelial system clearance, and high tumor accumulation. Liu X; Li H; Chen Y; Jin Q; Ren K; Ji J Adv Healthc Mater; 2014 Sep; 3(9):1439-47. PubMed ID: 24550205 [TBL] [Abstract][Full Text] [Related]
6. In vitro macrophage uptake and in vivo biodistribution of PLA-PEG nanoparticles loaded with hemoglobin as blood substitutes: effect of PEG content. Sheng Y; Yuan Y; Liu C; Tao X; Shan X; Xu F J Mater Sci Mater Med; 2009 Sep; 20(9):1881-91. PubMed ID: 19365612 [TBL] [Abstract][Full Text] [Related]
7. Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. Arnida ; Janát-Amsbury MM; Ray A; Peterson CM; Ghandehari H Eur J Pharm Biopharm; 2011 Apr; 77(3):417-23. PubMed ID: 21093587 [TBL] [Abstract][Full Text] [Related]
8. Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice. Oyewumi MO; Yokel RA; Jay M; Coakley T; Mumper RJ J Control Release; 2004 Mar; 95(3):613-26. PubMed ID: 15023471 [TBL] [Abstract][Full Text] [Related]
9. Tailored Dual PEGylation of Inorganic Porous Nanocarriers for Extremely Long Blood Circulation in Vivo. Nissinen T; Näkki S; Laakso H; Kučiauskas D; Kaupinis A; Kettunen MI; Liimatainen T; Hyvönen M; Valius M; Gröhn O; Lehto VP ACS Appl Mater Interfaces; 2016 Dec; 8(48):32723-32731. PubMed ID: 27934159 [TBL] [Abstract][Full Text] [Related]
10. Modeling gold nanoparticle biodistribution after arterial infusion into perfused tissue: effects of surface coating, size and protein corona. Riviere JE; Jaberi-Douraki M; Lillich J; Azizi T; Joo H; Choi K; Thakkar R; Monteiro-Riviere NA Nanotoxicology; 2018 Dec; 12(10):1093-1112. PubMed ID: 29856247 [TBL] [Abstract][Full Text] [Related]
11. The effect of ligand composition on the in vivo fate of multidentate poly(ethylene glycol) modified gold nanoparticles. Liu X; Huang N; Wang H; Li H; Jin Q; Ji J Biomaterials; 2013 Nov; 34(33):8370-81. PubMed ID: 23932246 [TBL] [Abstract][Full Text] [Related]
12. Cellular Uptake and Tissue Biodistribution of Functionalized Gold Nanoparticles and Nanoclusters. Escudero-Francos MA; Cepas V; González-Menédez P; Badía-Laíño R; Díaz-García ME; Sainz RM; Mayo JC; Hevia D J Biomed Nanotechnol; 2017 Feb; 13(2):167-79. PubMed ID: 29377647 [TBL] [Abstract][Full Text] [Related]
13. Influence of PEG coating on the oral bioavailability of gold nanoparticles in rats. Alalaiwe A; Roberts G; Carpinone P; Munson J; Roberts S Drug Deliv; 2017 Nov; 24(1):591-598. PubMed ID: 28222611 [TBL] [Abstract][Full Text] [Related]
14. Critical parameters in the pegylation of gold nanoshells for biomedical applications: an in vitro macrophage study. Kah JC; Wong KY; Neoh KG; Song JH; Fu JW; Mhaisalkar S; Olivo M; Sheppard CJ J Drug Target; 2009 Apr; 17(3):181-93. PubMed ID: 19016072 [TBL] [Abstract][Full Text] [Related]
15. Pegylated magnetic nanocarriers for doxorubicin delivery: a quantitative determination of stealthiness in vitro and in vivo. Allard-Vannier E; Cohen-Jonathan S; Gautier J; Hervé-Aubert K; Munnier E; Soucé M; Legras P; Passirani C; Chourpa I Eur J Pharm Biopharm; 2012 Aug; 81(3):498-505. PubMed ID: 22510695 [TBL] [Abstract][Full Text] [Related]
16. Blood-nanoparticle interactions and in vivo biodistribution: impact of surface PEG and ligand properties. Shah NB; Vercellotti GM; White JG; Fegan A; Wagner CR; Bischof JC Mol Pharm; 2012 Aug; 9(8):2146-55. PubMed ID: 22668197 [TBL] [Abstract][Full Text] [Related]
17. Preventing protein adsorption and macrophage uptake of gold nanoparticles via a hydrophobic shield. Larson TA; Joshi PP; Sokolov K ACS Nano; 2012 Oct; 6(10):9182-90. PubMed ID: 23009596 [TBL] [Abstract][Full Text] [Related]
18. Size- and surface chemistry-dependent pharmacokinetics and tumor accumulation of engineered gold nanoparticles after intravenous administration. Wang J; Bai R; Yang R; Liu J; Tang J; Liu Y; Li J; Chai Z; Chen C Metallomics; 2015 Mar; 7(3):516-24. PubMed ID: 25671498 [TBL] [Abstract][Full Text] [Related]
19. Accumulation of magnetic iron oxide nanoparticles coated with variably sized polyethylene glycol in murine tumors. Larsen EK; Nielsen T; Wittenborn T; Rydtoft LM; Lokanathan AR; Hansen L; Østergaard L; Kingshott P; Howard KA; Besenbacher F; Nielsen NC; Kjems J Nanoscale; 2012 Apr; 4(7):2352-61. PubMed ID: 22395568 [TBL] [Abstract][Full Text] [Related]
20. The One Year Fate of Iron Oxide Coated Gold Nanoparticles in Mice. Kolosnjaj-Tabi J; Javed Y; Lartigue L; Volatron J; Elgrabli D; Marangon I; Pugliese G; Caron B; Figuerola A; Luciani N; Pellegrino T; Alloyeau D; Gazeau F ACS Nano; 2015 Aug; 9(8):7925-39. PubMed ID: 26168364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]